Haemonetics Corporation (HAE) Profit Margins
Over the twelve months to 2026-06-30, Haemonetics Corporation (HAE) had gross margin 59.0%, operating margin 11.9%, net margin 7.1%, free cash flow margin 21.5%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HAEHaemonetics CorporationFollow HAE — free
—
Price chart with a free account
- Market cap
- 5.4B
- P/E TTM
- 57.3
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2012 Mar 12 | FY2013 Mar 13 | FY2014 Mar 14 | FY2015 Mar 15 | FY2019 Mar 19 | FY2020 Mar 20 | FY2021 Apr 21 | FY2022 Apr 22 | FY2023 Apr 23 | FY2024 Mar 24 | FY2025 Mar 25 | FY2026 Mar 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 50.7% | 48.0% | 49.9% | 47.7% | 43.2% | 49.0% | 45.7% | 50.9% | 52.6% | 52.8% | 55.0% | 59.0% | 59.0% | |
| Operating margin | 12.2% | 6.3% | 4.9% | 4.5% | 8.6% | 10.5% | 10.3% | 8.1% | 13.4% | 12.6% | 16.3% | 11.7% | 11.9% | |
| Net margin | 9.2% | 4.3% | 3.7% | 1.9% | 5.7% | 7.7% | 9.1% | 4.4% | 9.9% | 9.0% | 12.3% | 7.3% | 7.1% | |
| FCF margin | 8.5% | 2.6% | 7.0% | 0.5% | 4.2% | 11.1% | 8.2% | 7.6% | 7.0% | 11.0% | 10.5% | 19.5% | 21.5% |
USD billions · SEC XBRL
Haemonetics Corporation — questions
- What is Haemonetics Corporation's gross margin?
- 59.0% over the twelve months to 2026-06-30.
- What is Haemonetics Corporation's operating margin?
- 11.9% over the twelve months to 2026-06-30.
- What is Haemonetics Corporation's net profit margin?
- 7.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Haemonetics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.